-The Times of India Crest Cash transfers have been described as the world's favourite new anti-poverty device. As India gets set to implement it, TOI-Crest finds out if the politics will ever be divorced from the cash The UPA government's ambitious plan to introduce direct cash transfers (DCT) by January 1, 2013 reflects both the political desperation of a beleaguered government and the urgent need to reform India's inefficient and corrupt public...

-The Business Standard Are these people expected to return to their villages and hometowns to hang around waiting for the Unique Identification Authority of India to set up shop?  Workers returning to their jobs in metros from remote villages in Bihar and Jharkhand have lately been complaining that they are barred from boarding trains unless they show sufficient identification, including proof of residence in cities. Whether this is a run-up to the...

-The Indian Express Lamenting the virtual collapse of public health system in major parts of the country, Union Minister Jairam Ramesh today said rural families are falling into debt trap due to expensive private health sector. In large parts of the country, particularly in central and eastern India and in tribal belts, he said public health system is "not abysmal but has collapsed". "Indebtedness caused by private health sector is one of the...

-Outlook Its ploy of Aadhar-hinged cash transfer may have won the Congress political points, but will it really be a game-changer?   State-Wise     40% of the 22 crore Aadhar numbers are in Andhra Pradesh (4.7 crore) and Maharashtra (4 crore)     20% is what the two politically sensitive, Congress-ruled states account for of the 51 districts where DCT will be rolled out     55 lakh Aadhar numbers in TMC-run West Bengal. BJP-ruled Gujarat (57...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...